Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT04999631
EARLY_PHASE1

SADBE for Congenital Melanocytic Nevi

Sponsor: Massachusetts General Hospital

View on ClinicalTrials.gov

Summary

A study to evaluate the safety and efficacy topical squaric acid dibutylester (SADBE) for the neoadjuvant treatment of congenital melanocytic nevi (CMN).

Official title: Neoadjuvant Squaric Acid Dibutylester Treatment of Melanocytes in Congenital Melanocytic Nevi

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2022-01-01

Completion Date

2028-01-01

Last Updated

2021-10-28

Healthy Volunteers

No

Interventions

DRUG

Squaric Acid Dibutyl Ester

Topical squaric acid dibutyl ester (SADBE) dissolved in ethanol at 0.2% concentration.

DRUG

Ethanol Solution

Control